Carbon Monoxide Produced by Heme Oxygenase-1 Suppresses T Cell Proliferation via Inhibition of IL-2 Production

Journal of Immunology

Volumn 172, Issue 8, 2004, Pages 4744-4751

  Pae, Hyun Ock ^a   Oh, Gi Su ^a   Choi, Byung Min ^a   Chae, Soo Cheon ^a   Kim, Young Myeong ^b   Chung, Khee Rhin ^c   Chung, Hun Taeg ^a  

^a Wonkwang University   (South Korea)

^b Kangwon National University College of Medicine   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BILIVERDIN; CARBON MONOXIDE; CD28 ANTIGEN; CD3 ANTIGEN; CYCLIC GMP; GUANYLATE CYCLASE; HEME; HEME OXYGENASE 1; INTERLEUKIN 10; INTERLEUKIN 2; IRON; MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; CELL CYCLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOCYTE PROLIFERATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 1842529311     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.8.4744     Document Type: Article

References (32)

1. + T cells. Biochem. Biophys. Res. Commun. 306:701.
2. Song, R., M. Kubo, D. Morse, Z. Zhou, X. Zhang, J. H. Dauber, J. Fabisiak, S. M. Alber, S. C. Watkins, B. S. Zuckerbraun, et al. 2003. Carbon monoxide induces cytoprotection in rat orthotopic lung transplantation via anti-inflammatory and anti-apoptotic effects. Am. J. Pathol. 163:231.
3. 12,14-prostaglandin J2. J. Biol. Chem. 278:19325.
4. Poss, K. D., and S. Tonegawa. 1997. Reduced stress defense in heme oxygenase 1-deficient cells. Proc. Natl. Acad. Sci. USA 94:10925.
5. Poss, K. D., and S. Tonegawa. 1997. Heme oxygenase 1 is required for mammalian iron reutilization. Proc. Natl. Acad. Sci. USA 94:10919.
6. Kawashima, A., Y. Oda, A. Yachie, S. Koizumi, and I. Nakanishi. 2002. Heme oxygenase-1 deficiency: the first autopsy case. Hum. Pathol. 33:125.
7. Santana, M. A., and Y. Rosenstein. 2003. What it takes to become an effector T cell: the process, the cells involved, and the mechanisms. J. Cell. Physiol. 195:392.
8. Dong, C., R. J. Davis, and R. A. Flavell. 2002. MAP kinases in the immune response. Annu. Rev. Immunol. 20:55.
9. Alberola-Ila, J., and G. Hernandez-Hoyos. 2003. The Ras/MAPK cascade and the control of positive selection. Immunol. Rev. 191:79.
10. Schwartz, R. H. 1977. T cell clonal anergy. Curr. Opin. Immunol. 9:351.
11. ras couples the T cell antigen receptor to extra signal regulated kinase in T cells. J. Exp. Med. 78:1199.
12. Angel, P., and M. Karin. 1991. The role of Jun, Fos and the AP-1 complex in cell proliferation and transformation. Biochim. Biophys. Acta 1072:129.
13. + T cells. Science 271:1272.
14. DeSilva, D. R., E. A. Jones, M. F. Favata, B. D. Jaffee, R. L. Magolda, J. M. Trzaskos, and P. A. Scherle, 1998. Inhibition of mitogen-activated protein kinase kinase blocks T cell proliferation but does not induce or prevent anergy. J. Immunol. 160:4175.
15. Soares, M. P., Y. Lin, J. Anrather, E. Csizmadia, K. Takigami, K. Sato, S. T. Grey, R. B. Colvin, A. M. Choi, K. D. Poss, and F. H. Bach. 1998. Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat. Med. 4:1073.
16. Sato, K., J. Balla, L. Otterbein, R. N. Smith, S. Brouard, Y. Lin, E. Csizmadia, J. Sevigny, S. C. Robson, G. Vercellotti, et al. 2001. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J. Immunol. 166:4185.
17. Otterbein, L. E., M. P. Soares, K. Yamashita, and F. H. Bach. 2003. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 24:449.
18. Zhang, X., P. Shan, L. E. Otterbein, J. Alam, R. A. Flavell, R. J. Davis, A. M. Choi, and P. J. Lee. 2003. Carbon monoxide inhibition of apoptosis during ischemia-reperfusion lung injury is dependent on the p38 mitogen-activated protein kinase pathway and involves caspase 3. J. Biol. Chem. 278:1248.
19. Choi, B. M., H. O. Pae, Y. M. Kim, and H. T. Chung. 2003. Nitric oxide-mediated cytoprotection of hepatocytes from glucose deprivation-induced cytotoxicity: involvement of heme oxygenase-1. Hepatology 37:810.
20. Otterbein, L. E., B. S. Zuckerbraun, M. Haga, F. Liu, R. Song, A. Usheva, C. Stachulak, N. Bodyak, R. N. Smith, E. Csizmadia, et al. 2003. Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat. Med. 9:183.
21. Song, R., R. S. Mahidhara, F. Liu, W. Ning, L. E. Otterbein, and A. M. Choi. 2002. Carbon monoxide inhibits human airway smooth muscle cell proliferation via mitogen-activated protein kinase pathway. Am. J. Respir. Cell Mol. Biol. 27:603.
22. Otterbein, L. E., F. H. Bach, J. Alam, M. Soares, H. Tao Lu, M. Wysk, R. J. Davis, R. A. Flavell, and A. M. Choi. 2000. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat. Med. 6:422.
23. Chow, S., H. Patel, and D. W. Hedley. 2001. Measurement of MAP kinase activation by flow cytometry using phospho-specific antibodies to MEK and ERK: potential for pharmacodynamic monitoring of signal transduction inhibitors. Cytometry 46:72.
24. Lafont, V., B. Rouot, and J. Favero. 1998. The Raf-1/mitogen-activated protein kinase kinase-1/extracellular signal-regulated-2 signaling pathway as prerequisite for interleukin-2 gene transcription in lectin-stimulated human primary T lymphocytes. Biochem. Pharmacol. 55:319.
25. Franklin, R. A., A. Tordai, H. Patel, A. M. Gardner, G. L. Johnson, and E. W. Gelfand. 1994. Ligation of the T cell receptor complex results in activation of the Ras/Raf-1/MEK/MAPK cascade in human T lymphocytes. J. Clin. Invest. 93:2134.
26. Chen, D., V. Heath, A. O'Garra, J. Johnston, and M. McMahon. 1999. Sustained activation of the raf-MEK-ERK pathway elicits cytokine unresponsiveness in T cells. J. Immunol. 63:5796.
27. Chang, F., L. S. Steelman, J. T. Lee, J. G. Shelton, P. M. Navolanic, W. L. Blalock, R. A. Franklin, and J. A. McCubrey. 2003. Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention. Leukemia 17:1263.
28. Lee, T. S., and L. Y. Chau. 2002. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat. Med. 8:240.
29. Araujo, J. A., L. Meng, A. D. Tward, W. W. Hancock, Y. Zhai, A. Lee, K. Ishikawa, S. Iyer, R. Buelow, R. W. Busuttil, et al. 2003. Systemic rather than local heme oxygenase-1 overexpression improves cardiac allograft outcomes in a new transgenic mouse. J. Immunol. 171:1572.
30. Woo, J., S. Iyer, M. C. Cornejo, N. Mori, L. Gao, I. Sipos, M. Maines, and R. Buelow. 1998. Stress protein-induced immunosuppression: inhibition of cellular immune effector functions following overexpression of haem oxygenase (HSP 32). Transplant Immunol. 6:84.
31. Liu, Y., B. Zhu, L. Luo, P. Li, D. W. Paty, and M. S. Cynader. 2001. Heme oxygenase-1 plays an important protective role in experimental autoimmune encephalomyelitis. NeuroReport. 12:1841.
32. Boussiotis, V. A., G. J. Freeman, A. Berezovskaya, D. L. Barber, and L. M. Nadler. 1997. Maintenance of human T cell anergy: blocking of IL-2 gene transcription by activated Rapl. Science 278:124.